Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2023-03-23 00:00:00 ET · period of report 2023-03-21 · accession 0001209191-23-020846 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-23 | 2023-03-21+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +22.7K | 542.1K | +4% | +$13.9K |
| DM | 2023-03-23 | 2023-03-21+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.00 | -22.7K | 528.0K | -4% | -$363.6K |
| DM | 2023-03-23 | 2023-03-21+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.00 | -22.7K | 252.2K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-23 | M | A | 4,827 | $0.61 | 532,808 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-23 | S | D | 4,827 | $16.00 | 527,981 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-22 | S | D | 3,800 | $16.00 | 527,981 | D | — | — | |
| 4 | Common | Common Stock | 2023-03-22 | M | A | 3,800 | $0.61 | 531,781 | D | — | — | |
| 5 | Common | Common Stock | 2023-03-21 | S | D | 14,100 | $16.00 | 527,981 | D | — | — | |
| 6 | Common | Common Stock | 2023-03-21 | M | A | 14,100 | $0.61 | 542,081 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-03-21 | M | D | 14,100 | $0.00 | 256,029 | D | $0.61 · — to 2030-01-26 | 14,100 Common Stock | (F2) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-03-23 | M | D | 4,827 | $0.00 | 247,402 | D | $0.61 · — to 2030-01-26 | 4,827 Common Stock | (F2) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-03-22 | M | D | 3,800 | $0.00 | 252,229 | D | $0.61 · — to 2030-01-26 | 3,800 Common Stock | (F2) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |